Prevalence of High Aldosterone-Renin Ratio in Patients With Hypertension in Basrah.

Autor:	Zwain Z; Diabetes and Endocrinology, Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC) University of Basrah, Basrah, IRQ., Nwayyir HA; Medicine, University of Basrah College of Medicine, Basrah, IRQ., Alidrisi HA; Diabetes and Endocrinology, University of Basrah College of Medicine, Basrah, IRQ., Mansour AA; Diabetes and Endocrinology, Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC) University of Basrah, Basrah, IRQ.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2023 Mar 13; Vol. 15 (3), pp. e36085. Date of Electronic Publication: 2023 Mar 13 (Print Publication: 2023).
DOI:	10.7759/cureus.36085
Abstrakt:	Background and Aim: Aldosterone-renin ratio (ARR) is an important screening tool for the assessment of primary aldosteronism as a cause of secondary hypertension. This study aimed to measure the prevalence of patients with elevated ARR among samples of Iraqi patients with hypertension. Methods: A retrospective study was conducted at Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC) in Basrah during the period of February 2020 to November 2021. We evaluated the records of patients with hypertension whom were screened for endocrine cause, and an ARR cut-off equal or more than 5.7 was considered elevated. Results: Of the total 150 patients enrolled, 39 (26%) of them had an elevated ARR. No statistically significant association for the elevated ARR with age, gender, BMI, duration of hypertension, systolic and diastolic blood pressure, pulse rate, and presence or absence of diabetes mellitus or lipid profile. Conclusion: High frequency of elevated ARR was seen in 26% of patients with hypertension. More studies need to be conducted in the future taking larger samples. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Zwain et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu